CELLINK 3D Prints Miniature Ears & Unveils First Universal Bioink for Printing Living Tissue
Science-fiction has always been enamored by the idea of humans creating other human beings, or robots that appear to be human themselves. While this probably won’t ever happen, at least in our lifetimes, the possibility of 3D printing entire organs may actually become a reality sometime in the coming decades. The idea of being able to forego the need for donor organs, and simply 3D print one in a lab, has many tremendous benefits. Lives would be saved, risks reduced, and life expectancy could conceivable be extended for hundreds of years.
3D bioprinting, as it is called, has been quite a hot topic within the medical space as of late. There are companies out there such as Organovo and BioBots who are building machines capable of printing real human tissue. Organovo expects to be able to 3D print parts of organs which can then be transplanted onto a person’s faulty organ in order to extend its capabilities, within the coming decade.
Now one startup company, CELLINK looks to create a standard for the 3D bioprinting industry, with their newly unveiled universal bioink which is aimed at 3D printing living and fully functional 3D tissue models.
“Every year, the U.S. Government spends about $20 billion on tissue engineering,” CELLINK representatives explain. “Every month, pharma companies spend about $500 million on drug development, [and] only 1 in 9 succeed. Every day, 21 patients die while waiting for an organ transplant. CELLINK is the final puzzle piece in the 3D bioprinting industry we all have been waiting for.”
That final puzzle piece is a bioink which can be used on a range of available 3D bioprinters, as well as a standalone product which can be used to perform experimental 3D cell culturing. With today’s 3D bioprinters, two separate extruders are typically used; one for laying down a “bioink” and another for laying down the cells onto that ink. With CELLINK, the cells and the bioink may be mixed together as one in a process that allows a single nozzle on a bioprinter to lay down both the bioink and the cells all at once. This further allows for greater detail and precision, as well as the ability to speed up the printing process significantly.
“CELLINK provides you with the printability you have been waiting for,” the company explains. “It offers ideal shape fidelity and stiffness of structures after crosslinking. The optimal composition of our ink makes printing elegantly simple.”
As for the CELLINK Bioink, it is now available for purchase, starting at $99.00 for 3ml or $199 for 10ml. Of course you probably want to know what you are doing before you try and 3D print living cells.
The company, which has showed off this technology by 3D printing miniature ears, currently is looking to expand their presence and increase the types of human tissue capable of being printed.
What do you think about this incredible new “bioink”? Will this speed up the development of new bio-applications for 3D printers? Discuss in the CELLINK forum thread on 3DPB.com.
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
3D Printing Financials: Xometry Surges After Record Quarter and Siemens Deal
Shares of Xometry (Nasdaq: XMTR) surged on Thursday, May 7, after the company reported record first-quarter 2026 results and announced a major partnership with Siemens. The stock climbed as much...
3D Printing Financials: Materialise Improves Margins Despite Flat Revenue
Materialise (Euronext and NASDAQ: MTLS) started 2026 with stable revenue, stronger margins, and better operating profit, helped by growth in medical and improved profitability in software. The Belgian 3D printing...
3D Printing News Briefs: May 7, 2026: Metal Powder Bed Fusion, Surgical Plates, & More
In today’s 3D Printing News Briefs, we’ll start with a strategic collaboration to advance next-generation metal additive manufacturing (AM), before moving on to funding for surgical research. We’ll end with...
3D Printing Financials: Protolabs Starts 2026 Strong, with Metal Printing Leading
Protolabs (NYSE: PRLB) kicked off 2026 with a strong quarter, showing steady growth, better margins, and improving customer engagement, even though some parts of the business, especially 3D printing in...





































